Targets for Alzheimer's disease: Lessons learnt from flies

M. Konsolaki, D. Cohen

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Neurodegenerative diseases, including Alzheimer's disease (AD), are a major focus of the pharmaceutical industry. Recently, human genetic analyses have aided in the successful identification of a handful of genes responsible for genetically inherited forms of AD, but our understanding of basic mechanisms that lead to the more common sporadic forms of this disease is still limited.

Original languageEnglish (US)
Pages (from-to)64-70
Number of pages7
JournalDrug Discovery Today: TARGETS
Issue number2
StatePublished - Apr 2004
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Drug Discovery


  • Alzheimer's Disease
  • Drosophila
  • Drug Discovery
  • Genetics
  • Molecular Medicine
  • Neurobiology
  • Pharmaceutical Science
  • beta-amyloid
  • disease pathways
  • genetic analysis


Dive into the research topics of 'Targets for Alzheimer's disease: Lessons learnt from flies'. Together they form a unique fingerprint.

Cite this